03Dec 2022
Neuropeptide Y Antagonizes Development of Pulmonary Fibrosis through IL-1β Inhibition

Neuropeptide Y Antagonizes Development of Pulmonary Fibrosis through IL-1β Inhibition

This study was performed to determine the effects of NPY on pulmonary fibrosis. NPY-deficient and wild-type mice were intratracheally administered bleomycin. Inflammatory cells, cytokine concentrations, and morphological morphometry of the lungs were analyzed. NPY expression was mainly observed around bronchial epithelial cells in human idiopathic pulmonary fibrosis lungs. These data suggest that NPY plays a protective role against pulmonary fibrosis by suppressing IL-1β release, and manipulating the NPY–Y1 receptor axis could be a potential therapeutic strategy for delaying disease progression.

  • #pulmonology

Like

Save

Share